Annual CFF
$6.49 M
-$14.51 M-69.08%
September 30, 2024
Summary
- As of February 6, 2025, SONN annual cash flow from financing activities is $6.49 million, with the most recent change of -$14.51 million (-69.08%) on September 30, 2024.
- During the last 3 years, SONN annual CFF has fallen by -$36.33 million (-84.83%).
- SONN annual CFF is now -84.83% below its all-time high of $42.83 million, reached on September 30, 2021.
Performance
SONN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$234.70 K
-$3.08 M-108.24%
September 30, 2024
Summary
- As of February 6, 2025, SONN quarterly cash flow from financing activities is -$234.70 thousand, with the most recent change of -$3.08 million (-108.24%) on September 30, 2024.
- Over the past year, SONN quarterly CFF has dropped by -$3.08 million (-108.24%).
- SONN quarterly CFF is now -100.85% below its all-time high of $27.53 million, reached on September 30, 2021.
Performance
SONN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$6.50 M
-$217.00 K-3.23%
September 30, 2024
Summary
- As of February 6, 2025, SONN TTM cash flow from financing activities is $6.50 million, with the most recent change of -$217.00 thousand (-3.23%) on September 30, 2024.
- Over the past year, SONN TTM CFF has dropped by -$217.00 thousand (-3.23%).
- SONN TTM CFF is now -84.84% below its all-time high of $42.85 million, reached on December 31, 2021.
Performance
SONN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SONN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -69.1% | -108.2% | -3.2% |
| 3 y3 years | -84.8% | -108.2% | -3.2% |
| 5 y5 years | +187.9% | -108.2% | -3.2% |
SONN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.8% | +61.8% | -101.6% | at low | -84.8% | +61.8% |
| 5 y | 5-year | -84.8% | +187.9% | -100.8% | at low | -84.8% | +226.9% |
| alltime | all time | -84.8% | +187.9% | -100.8% | at low | -84.8% | +226.9% |
Sonnet BioTherapeutics Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $6.49 M(-69.1%) | -$234.70 K(-108.2%) | $6.50 M(-3.2%) |
| Jun 2024 | - | $2.85 M(+6850.7%) | $6.71 M(+18.2%) |
| Mar 2024 | - | $41.00 K(-98.9%) | $5.68 M(-72.0%) |
| Dec 2023 | - | $3.84 M(<-9900.0%) | $20.28 M(-3.4%) |
| Sep 2023 | $21.01 M(+423.3%) | -$17.70 K(-101.0%) | $21.01 M(-16.1%) |
| Jun 2023 | - | $1.81 M(-87.6%) | $25.04 M(+7.8%) |
| Mar 2023 | - | $14.65 M(+221.0%) | $23.22 M(+170.8%) |
| Dec 2022 | - | $4.56 M(+13.7%) | $8.58 M(+113.7%) |
| Sep 2022 | $4.01 M | $4.01 M(>+9900.0%) | $4.01 M(-85.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $0.00(0.0%) | $27.53 M(-15.7%) |
| Mar 2022 | - | $0.00(0.0%) | $32.67 M(-23.8%) |
| Dec 2021 | - | $0.00(-100.0%) | $42.85 M(+0.0%) |
| Sep 2021 | $42.83 M(+86.2%) | $27.53 M(+435.1%) | $42.83 M(+179.9%) |
| Jun 2021 | - | $5.14 M(-49.5%) | $15.30 M(+50.6%) |
| Mar 2021 | - | $10.18 M(<-9900.0%) | $10.16 M(+411.2%) |
| Dec 2020 | - | -$20.10 K(-101.0%) | $1.99 M(-1.0%) |
| Sep 2020 | $23.01 M(+919.8%) | - | - |
| Mar 2020 | - | $2.01 M | $2.01 M |
| Sep 2019 | $2.26 M | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual CFF year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly CFF year-on-year change?
- What is Sonnet BioTherapeutics Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings TTM CFF year-on-year change?
What is Sonnet BioTherapeutics Holdings annual cash flow from financing activities?
The current annual CFF of SONN is $6.49 M
What is the all time high annual CFF for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual cash flow from financing activities is $42.83 M
What is Sonnet BioTherapeutics Holdings annual CFF year-on-year change?
Over the past year, SONN annual cash flow from financing activities has changed by -$14.51 M (-69.08%)
What is Sonnet BioTherapeutics Holdings quarterly cash flow from financing activities?
The current quarterly CFF of SONN is -$234.70 K
What is the all time high quarterly CFF for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly cash flow from financing activities is $27.53 M
What is Sonnet BioTherapeutics Holdings quarterly CFF year-on-year change?
Over the past year, SONN quarterly cash flow from financing activities has changed by -$3.08 M (-108.24%)
What is Sonnet BioTherapeutics Holdings TTM cash flow from financing activities?
The current TTM CFF of SONN is $6.50 M
What is the all time high TTM CFF for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM cash flow from financing activities is $42.85 M
What is Sonnet BioTherapeutics Holdings TTM CFF year-on-year change?
Over the past year, SONN TTM cash flow from financing activities has changed by -$217.00 K (-3.23%)